Cite

HARVARD Citation

    Glutsch, V. et al. (2019). Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapy. Journal for immunotherapy of cancer. 7 (1), p. . [Online]. 
  
Back to record